Simplex Trading’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,692
| Closed | -$71.6K | – | 11171 |
|
|
2022
Q3 | $32K | Sell |
8,692
-27,776
| -76% | -$128K | ﹤0.01% | 7010 |
|
|
2022
Q2 | $216K | Sell |
36,468
-1,351
| -4% | -$7.62K | ﹤0.01% | 4509 |
|
|
2022
Q1 | $239K | Buy |
+37,819
| New | +$212K | ﹤0.01% | 4899 |
|
|
2020
Q1 | – | Sell |
-2,512
| Closed | -$7.35K | – | 8745 |
|
|
2019
Q4 | $7K | Sell |
2,512
-872
| -26% | -$3.49K | ﹤0.01% | 6594 |
|
|
2019
Q3 | $15K | Buy |
3,384
+2,177
| +180% | +$10.9K | ﹤0.01% | 6036 |
|
|
2019
Q2 | $5K | Buy |
1,207
+1,089
| +923% | +$5.16K | ﹤0.01% | 6502 |
|
|
2019
Q1 | $0 | Buy |
+118
| New | +$542 | ﹤0.01% | 8414 |
|
|
2018
Q4 | – | Sell |
-656
| Closed | -$2K | – | 8479 |
|
|
2018
Q3 | $2K | Sell |
656
-497
| -43% | -$2.09K | ﹤0.01% | 7150 |
|
|
2018
Q2 | $4K | Buy |
+1,153
| New | +$7.66K | ﹤0.01% | 6863 |
|
|
2018
Q1 | – | Sell |
-1,008
| Closed | -$8.34K | – | 7500 |
|
|
2017
Q4 | $8K | Sell |
1,008
-4,344
| -81% | -$40.5K | ﹤0.01% | 4154 |
|
|
2017
Q3 | $61K | Sell |
5,352
-10,413
| -66% | -$109K | ﹤0.01% | 2138 |
|
|
2017
Q2 | $153K | Buy |
15,765
+10,630
| +207% | +$217K | 0.01% | 1411 |
|
|
2017
Q1 | $124K | Sell |
5,135
-2,657
| -34% | -$66.5K | 0.01% | 1564 |
|
|
2016
Q4 | $250K | Sell |
7,792
-1,628
| -17% | -$69.4K | 0.01% | 899 |
|
|
2016
Q3 | $470K | Buy |
9,420
+8,551
| +984% | +$355K | 0.03% | 541 |
|
|
2016
Q2 | $36K | Sell |
869
-103
| -11% | -$5.61K | ﹤0.01% | 2378 |
|
|
2016
Q1 | $63K | Sell |
972
-658
| -40% | -$34.3K | 0.01% | 1757 |
|
|
2015
Q4 | $101K | Buy |
+1,630
| New | +$115K | 0.01% | 1358 |
|
|
2015
Q3 | – | Sell |
-807
| Closed | -$65.9K | – | 6662 |
|
|
2015
Q2 | $78K | Buy |
+807
| New | +$76.8K | 0.01% | 1366 |
|
Simplex Trading's MACK Position: Q4 2022 in Review
Simplex Trading sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2022, closing a stake of 8,692 shares — an estimated $71.6K sold.
Simplex Trading first reported a position in MACK in Q2 2015 and held it in 19 quarters. The position peaked at $470K in Q3 2016. 47 funds tracked by Wall St. Rank hold MACK as of Q4 2022.
- Simplex Trading reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
- Simplex Trading sold 8,692 Merrimack Pharmaceuticals, Inc. shares in Q4 2022, an estimated $71.6K.
- Simplex Trading first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2015 and held it in 19 quarters.
- Simplex Trading's Merrimack Pharmaceuticals, Inc. position peaked at $470K in Q3 2016.
- 47 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2022.
Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.